The Food and Drug Administration said Tuesday that it approved Innoviva’s Xacduro pneumonia treatment, which fights the Acinetobacter bacteria.
You are here: Home / Top Stories / Dow Jones Newswires: FDA approves Innoviva’s bacterial pneumonia treatment